Table II.
Serum levels of Ape-1, ICAM-1 and IL-17A in the patients of the two groups (µg/l).
| Group/time-point | Ape-1 | ICAM-1 | IL-17A |
|---|---|---|---|
| Group A | |||
| Pre-SBRT | 16±1.21 | 19±0.92 | 14±0.69 |
| Post-SBRT | 21 | 18±0.48 | 19±1.09 |
| P-value | 0.02 | 0.01 | 0.02 |
| Group B | |||
| Pre-SBRT | <4.2±0.17 | <3.0±0.32 | <5.1±0.25 |
| Post-SBRT | <4.1±0.76 | <2.1±0.46 | <4.2±0.86 |
| P-value | 0.06 | 0.05 | 0.07 |
IL, interleukin; ICAM, intercellular adhesion molecule; Ape-1, apurinic/apyrimidinic endonuclease 1; SBRT, stereotactic body radiation therapy. P-value, Post-SBRT vs. Pre-SBRT. The median values 4.2, 3.0 and 5.1 µg/l were selected as cutoff values. Values are expressed as the mean ± standard deviation.